Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

dynaCERT on Haywood Securities’ radar, ESG benefactor ready to scale

James O'Rourke James O'Rourke, Clarity Analytics
0 Comments| June 3, 2020

{{labelSign}}  Favorites

dynaCERT Inc. (TSX-V: DYA) (OTCQB: DYFSF) (Frankfurt: DMJ) is the subject of coverage by analysts at Haywood Securities which issued an ‘Uncovered Radar Flash – Watchlist Report’ on June 2, 2020 entitled “An ESG Benefactor; A Carbon Emission Reduction Technology that Took Years to Perfect is Now Ready to Scale”. Environmental, Social, and Governance (ESG) investment themes are accelerating in interest and Haywood securities has identified dynaCERT Inc. as a top candidate for portfolio consideration.

The full report may be viewed at online.

dynaCERT’s HydraGENTM (HG) technology is proven (on diesel trucks) to result in up to 88.7% reduction in NOx emissions, ~50% reduction in CO, 6-19% reduction in CO2, up to 57.1% reduction in Total Hydrocarbon emissions, 55%+ reduction in particulate matter (no black smoke), and up to ~20% reduction in fuel consumption.

In the report the analysts from Haywood Securities provide a synopsis of dynaCERT’s technology product and the opportunity for investors. Key highlight sections include, 1) Perfecting the product, 2) Ready to scale with strategic partnerships, and 3) Value Proposition to end-user is attractive and more than just a green initiative.

The report discusses how the investment landscape has changed in the last year and that timing is right for an opportunity to scale ESG technologies. The Haywood analysts also discuss dynaCERT’s production capabilities, margins, and provide a rough 12-month forecast with both a Base Case and an Upside Case scenario;

Base Case (full capacity) = 24,000 units/yr. Revenue (as C$6,200/unit) = C$148M in revenues … Gross Profit (at 50% GM) = C$74M.
Upside Case (3 shifts) = 72,000 units/yr. Revenue (at C$6,200/unit) = C$446M in revenues … Gross Profit (at 50% GM) = C$223M.

Additionally, the analysts point out the future potential for recurring revenue streams from carbon credit revenue as an attractive added value proposition.

The Haywood analyst opinions mirror many of the points of the independent investment bank GBC AG, headquartered in Augsburg, Germany which currently has a near-term C$2/share price target on TSX-V: DYA. The GBC AG investment bank issued a conviction “BUY” recommendation several months earlier and outlines a pathway for significantly higher price potential (well beyond $2/share) via a multi-phase adoption curve covering three distinct product lines (each requiring their own set of specialized competences in various fields); 1) HydraGEN TM, 2) HydraLytica TM (dynaCERT’s proprietary software with remote real-time telematics which the Company has retained worldwide experts to establish an audit trail of fuel savings and future carbon credits), and 3) dynaCERT's carbon credit management system.

For further DD on dynaCERT Inc. see the following URLs:

Corporate website:

Investment bank GBC AG’s initial report from 2019:

The new Haywood Securities coverage report (June 2, 2020):

Recent Technology Journal Review:


James O’Rourke
James is a freelance information services professional for various media relation firms and financial publications. He monitors and invests in the resource, technology, consumer staples, healthcare, agriculture, financial, energy, utilities, and biotechnology/pharmaceutical sectors.
Legal Notice / Disclaimer
This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. The author has based this document on information obtained from sources he believes to be reliable but which has not been independently verified. The author makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author only and are subject to change without notice. The author assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Technical mining terms used by the writer may be used/expressed in simplified layman terms and should not be relied upon as appropriate for making investment decisions unless the reader contacts the company directly for independent verification. The author assumes no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information provided within this Report.

{{labelSign}}  Favorites

Get the latest news and updates from Stockhouse on social media


Featured Company